Expressions of C5a and its receptor CD88 after spinal cord injury in C3-deficient mice

Scandinavian Journal of Immunology

Volumn 77, Issue 4, 2013, Pages 224-229

  Guo, Q ^a   Cheng, J ^b   Zhang, H ^c   Zhang, J ^a   Su, B ^d   Bian, C ^a   Lin, S ^d  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b CHONGQING NORMAL UNIVERSITY   (China)

^c No 10 Hospital of Chinese People's Liberation Army   (China)

^d CHENGDU MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A RECEPTOR; PROTEIN; PROTEIN C3; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPLEMENT SYSTEM; FEMALE; IMMUNOHISTOCHEMISTRY; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINAL CORD INJURY; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING; WILD TYPE;

ANIMALS; COMPLEMENT C3; COMPLEMENT C5A; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOHISTOCHEMISTRY; MICE; MICE, KNOCKOUT; RECEPTOR, ANAPHYLATOXIN C5A; SPINAL CORD INJURIES; TIME FACTORS;

EID: 84875626288     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/sji.12001     Document Type: Article

References (23)

1. Guo Q, Li S, Liang Y et al. Effects of C3 deficiency on inflammation and regeneration following spinal cord injury in mice. Neurosci Lett 2010;485:32-6.
2. Imm MD, Feldhoff PW, Feldhoff RC, Lassiter HA. The administration of complement component C9 augments post- ischemiccerebral infarction volume in neonatal rats. Neurosci Lett 2002;325:175-8.
3. Nijmeijer R, Lagrand WK, Lubbers YT et al. C-reactive protein activates complement in infarcted human myocardium. Am J Pathol 2003;163:269-75.
4. Mukherjee P, Pasinetti GM. Complement anaphylatoxin C5a neuroprotects through mitogen-activated protein kinase-dependent inhibition of caspase 3. J Neurochem 2001;77:43-9.
5. Benard M, Gonzalez BJ, Schouft MT et al. Characterization of C3a and C5a receptors in rat cerebellar granule neurons during maturation. Neuroprotective effect of C5a against apoptotic cell death. J Biol Chem 2004;279:43487-96.
6. van Beek J, Elward K, Gasque P. Activation of complement in the central nervous system: roles in neurodegeneration and neuroprotection. Ann N Y Acad Sci 2003;992:56-71.
7. Guo RF, Wand PA. Role of C5a in inflammatory response. Annu Rev Immunol 2005;23:821-52.
8. Kwon BK, Tetzlaff W, Grauer JN, Beiner J, Vaccaro AR. Pathophysiology and pharmacologic treatment of acute spinal cord injury. Spine J 2004;4:451-64.
9. Mukherjee P, Thomas S, Pasinetti GM. Complement anaphylatoxin C5a neuroprotects through regulation of glutamate receptor subunit 2 in vitro and in vivo. J Neuroinflammation 2008;5:5.
10. O'BARR SA, Caguioa J, Gruol D et al. Neuronal expression of a functional receptor for the C5a complement activation fragment. J Immunol 2001;166:4154-62.
11. Rogers J, Strohmeyer R, Kovelowski CJ, Li R. Microglia and inflammatory mechanisms in the clearance of amyloid beta peptide. Glia 2002;40:260-9.
12. Kuhn PL, Wrathall JR. A mouse model of graded contusive spinal cord injury. J. Neurotrauma 1998;15:125-40.
13. Guo Q, Li SR, Su BY. Expression of oligodendrocyte myelin glocoprotein and its receptor NgR after the injury of rat central nervous system. Neurosci Lett 2007;422:103-8.
14. Thundyil J, Pavlovski D, Hsieh YH et al. C5a receptor (CD88) inhibition improves hypothermia-induced neuroprotection in an in vitro ischemic model. NeuroMol Med 2012;14:30-9.
15. Iyer A, Woodruff TM, Wu MC et al. Inhibition of inflammation and fibrosis by a complement C5a receptor antagonist in DOCA-salt hypertensive rats. J Cardiovasc Pharmacol 2011;58:479-86.
16. Huber-Lang M, Sarma JV, Zetoune FS et al. Generation of C5a in the absence of C3: a new complement activation pathway. Nat Med 2006;12:682-7.
17. Woodruff TM, Nandakumar KS, Tedesco F. Inhibiting the C5-C5a receptor axis. Mol Immunol 2011;48:1631-42.
18. Lee H, Whitfeld PL, Mackay CR. Receptors for complement C5a The importance of C5aR and the enigmatic role of C5L2. Immunol Cell Biol 2008;86:153-60.
19. Manthey HD, Woodruff TM, Taylor SM, Monk PN. Complement component 5a (C5a). Int J Biochem Cell Biol 2009;41:2114-7.
20. Woodruff TM, Ager RR, Tenner AJ, Noakes PG, Taylor SM. The role of the complement system and the activation fragment C5a in the central nervous system. NeuroMol Med 2010;12:179-92.
21. Liang DY, Li XQ, Shi XY et al. The complement component C5a receptor mediates pain and inflammation in a postsurgical pain model. Pain 2012;153:366-72.
22. Clark JD, Qiao Y, Li X, Shi X, Angst MS, Yeomans DC. Blockade of the complement C5a receptor reduces incisional allodynia, edema, and cytokine expression. Anesthesiology 2006;104:1274-82.
23. Monk PN, Scola AM, Madala P, Fairlie DP. Function, structure and therapeutic potential of complement C5a receptors. Br J Pharmacol 2007;152:429-48.